# Aclaris Therapeutics, Inc.: Material agreement entered (Form 8-K, 2026-10-27)

**Trigger Strength Score:** 40/100

| Field | Value |
|---|---|
| Company | Aclaris Therapeutics, Inc. |
| Ticker | ACRS |
| CIK | 1557746 |
| Filed | 2026-10-27 |
| Event date | 2026-10-27 |
| Primary trigger | Material agreement entered |
| All items | 1.01 Material agreement entered |
| Location | Wayne, PA |
| SIC code | 2834 |
| Accession | 0001104659-26-119231 |

## Why this score
- Primary trigger: Material agreement entered.

Source: SEC EDGAR Form 8-K current reports (https://www.sec.gov/Archives/edgar/data/1557746/000110465926119231/tm2628355d1_8k.htm). Last refreshed: 2026-11-04T09:16:40.251Z.
Event classification uses the item numbers companies report on Form 8-K; read the filing itself before acting. Informational only; not investment advice and not an offer or solicitation to buy or sell any security.
